These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7808020

  • 1. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
    Adamson PC.
    Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
    [Abstract] [Full Text] [Related]

  • 2. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
    Adamson PC.
    Leukemia; 1994 Nov; 8(11):1813-6. PubMed ID: 7967727
    [Abstract] [Full Text] [Related]

  • 3. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
    Adamson PC, Reaman G, Finklestein JZ, Feusner J, Berg SL, Blaney SM, O'Brien M, Murphy RF, Balis FM.
    J Clin Oncol; 1997 Nov; 15(11):3330-7. PubMed ID: 9363862
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
    Hirota T, Fujimoto T, Konno K, Sakakibara Y, Katano N, Tsurusawa M, Takitani K, Miyake M.
    Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
    [Abstract] [Full Text] [Related]

  • 5. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein.
    Adamson PC, Boylan JF, Balis FM, Murphy RF, Godwin KA, Gudas LJ, Poplack DG.
    Cancer Res; 1993 Feb 01; 53(3):472-6. PubMed ID: 8381046
    [Abstract] [Full Text] [Related]

  • 6. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia.
    Lanvers C, Reinhardt D, Dübbers A, Wagner-Bohn A, Creutzig U, Ritter J, Boos J.
    Med Pediatr Oncol; 2003 May 01; 40(5):293-301. PubMed ID: 12652617
    [Abstract] [Full Text] [Related]

  • 7. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.
    Masetti R, Biagi C, Zama D, Vendemini F, Martoni A, Morello W, Gasperini P, Pession A.
    Adv Ther; 2012 Sep 01; 29(9):747-62. PubMed ID: 22941525
    [Abstract] [Full Text] [Related]

  • 8. Retinoid therapy of childhood cancer.
    Reynolds CP, Lemons RS.
    Hematol Oncol Clin North Am; 2001 Oct 01; 15(5):867-910. PubMed ID: 11765378
    [Abstract] [Full Text] [Related]

  • 9. Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.
    Park SH, Gray WC, Hernandez I, Jacobs M, Ord RA, Sutharalingam M, Smith RG, Van Echo DA, Wu S, Conley BA.
    Clin Cancer Res; 2000 Mar 01; 6(3):847-54. PubMed ID: 10741706
    [Abstract] [Full Text] [Related]

  • 10. A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis.
    Trump DL, Smith DC, Stiff D, Adedoyin A, Day R, Bahnson RR, Hofacker J, Branch RA.
    Cancer Chemother Pharmacol; 1997 Mar 01; 39(4):349-56. PubMed ID: 9025776
    [Abstract] [Full Text] [Related]

  • 11. A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
    Adamson PC, Widemann BC, Reaman GH, Seibel NL, Murphy RF, Gillespie AF, Balis FM.
    Clin Cancer Res; 2001 Oct 01; 7(10):3034-9. PubMed ID: 11595692
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat.
    Ponthan F, Kogner P, Bjellerup P, Klevenvall L, Hassan M.
    Br J Cancer; 2001 Dec 14; 85(12):2004-9. PubMed ID: 11747346
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
    Ozpolat B, Lopez-Berestein G, Adamson P, Fu CJ, Williams AH.
    J Pharm Pharm Sci; 2003 Dec 14; 6(2):292-301. PubMed ID: 12935441
    [Abstract] [Full Text] [Related]

  • 14. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.
    Smith MA, Adamson PC, Balis FM, Feusner J, Aronson L, Murphy RF, Horowitz ME, Reaman G, Hammond GD, Fenton RM.
    J Clin Oncol; 1992 Nov 14; 10(11):1666-73. PubMed ID: 1403049
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.
    Sutton LM, Warmuth MA, Petros WP, Winer EP.
    Cancer Chemother Pharmacol; 1997 Nov 14; 40(4):335-41. PubMed ID: 9225952
    [Abstract] [Full Text] [Related]

  • 16. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
    Budd GT, Adamson PC, Gupta M, Homayoun P, Sandstrom SK, Murphy RF, McLain D, Tuason L, Peereboom D, Bukowski RM, Ganapathi R.
    Clin Cancer Res; 1998 Mar 14; 4(3):635-42. PubMed ID: 9533531
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
    Children's Oncology Group (CCG 09709)Children's Hospital Los Angeles and the Department Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, USA. jvillablanca@chla.usc.edu, Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, Reynolds CP.
    J Clin Oncol; 2006 Jul 20; 24(21):3423-30. PubMed ID: 16849757
    [Abstract] [Full Text] [Related]

  • 18. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM.
    Oncologist; 1997 Jul 20; 2(1):I-II. PubMed ID: 10388032
    [Abstract] [Full Text] [Related]

  • 19. All trans retinoic acid and cancer.
    Siddikuzzaman, Guruvayoorappan C, Berlin Grace VM.
    Immunopharmacol Immunotoxicol; 2011 Jun 20; 33(2):241-9. PubMed ID: 20929432
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
    Rizvi NA, Marshall JL, Ness E, Yoe J, Gill GM, Truglia JA, Loewen GR, Jaunakais D, Ulm EH, Hawkins MJ.
    Clin Cancer Res; 1998 Jun 20; 4(6):1437-42. PubMed ID: 9626460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.